The development of pevonedistat in myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML): hope or hype?

Myelodysplastic syndrome (MDS) is a clonal hematopoietic stem cell disorder clinically defined by cytopenias, bone marrow failure, and an increased risk of progressing to acute myeloid leukemia (AML). Traditionally, first-line treatment for patients with higher-risk MDS has been hypomethylating agen...

Descripción completa

Detalles Bibliográficos
Autores principales: Snow, Anson, Zeidner, Joshua F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9310330/
https://www.ncbi.nlm.nih.gov/pubmed/35898435
http://dx.doi.org/10.1177/20406207221112899

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9310330/
https://www.ncbi.nlm.nih.gov/pubmed/35898435
http://dx.doi.org/10.1177/20406207221112899

Ejemplares similares